C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom

Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
12/2004
12/23/2004	WO2004111004A1 Substituted piperazine carbamates for use as inhibitors of hormone sensitive lipase
12/23/2004	WO2004111003A1 Amide derivatives as selective serotonin re-uptake inhibitors
12/23/2004	WO2004111000A2 Piperidyl derivatives and their use as tachykinin antagonists
12/23/2004	WO2004110999A1 Tetrahydrocarbazole derivatives and their pharmaceutical use
12/23/2004	WO2004110997A1 3- sulfonylamino- pyrrolidine- 2- one derivatives as inhibitors of factor xa
12/23/2004	WO2004110996A1 Nk1 antagonist
12/23/2004	WO2004110994A1 Novel piperazinyl-aryloxy and piperazinyl-heteroaryloxy-n-aryl lactams
12/23/2004	WO2004110993A2 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
12/23/2004	WO2004110986A1 Benzamide derivative or salt thereof
12/23/2004	WO2004110453A1 Pyrimidine derivatives as cannabinoid receptor ligands
12/23/2004	WO2004110452A1 2-aminopyrimidine derivatives as raf kinase inhibitors
12/23/2004	WO2004110433A1 Pyrrolidin-1, 2- dicarboxylic acid- 1- [(4- ethinyl- phenyl) - amid]- 2- [(phenyl)- amid] derivative as inhibitors of coagulation factor xa and viia for the treatment of thrombosis
12/23/2004	WO2004110351A2 Heterocyclic compounds for treating hepatitis c virus
12/23/2004	WO2004110344A2 New azetidine compounds
12/23/2004	WO2004099150A3 3-(1-naphthyl)-2-cyanopropanoic acid derivatives as estrogen receptor ligands
12/23/2004	WO2004091518A3 Cxcr4 chemokine receptor binding compounds
12/23/2004	WO2004089908A3 3-azabicyclo[3.2.1]octane derivatives
12/23/2004	WO2004087048A3 Benzamide modulators of metabotropic glutamate receptors
12/23/2004	WO2004085409A3 Compounds and libraries of pyridines, pyrazines, imidazo[1,2-a]pyrazines and 1h-imidazo[4,5-b]pyrazin-2-ones and first and second medical uses thereof
12/23/2004	WO2004078128A3 Substituted pyridine derivatives useful in the treatment of cancer and other disorders
12/23/2004	WO2004072025A3 Substituted n-arylheterocycles, method for production and use thereof as medicaments
12/23/2004	WO2004071447A3 Substituted azole derivatives as therapeutic agents
12/23/2004	WO2004071390A3 Piperazine-2-carboxamide derivatives
12/23/2004	WO2004055010A3 Cyclopropyl compounds as ccr5 antagonists
12/23/2004	US20040260268 Drug/drug delivery systems for the prevention and treatment of vascular disease
12/23/2004	US20040260097 Insecticidal and acaricidal 3-substituted pyrazoles
12/23/2004	US20040260096 Novel substituted 4-phenyl-4-{1h-imidazol-2-yl}-piperidine derivatives and their use as selective non-peptide delta opioid agonists
12/23/2004	US20040260094 such as 8-amino-4-benzylamino-quinoline-3-carboxylic acid ethyl ester; for treatment of Alzheimer's disease, Huntington's disease, Parkinson's disease, AIDS, stroke, ischemia, traumatic brain injury, spinal cord injury or osteoarthritis
12/23/2004	US20040259928 Enzyme inhibitors for antidiabetic agents, antitumor disorders, treatment of skin disorters, anticancer agents and cognitive activators for Alzheimers disease treatment
12/23/2004	US20040259917 Heteroaryl substituted imidazole modulators of metabotropic glutamate receptor-5
12/23/2004	US20040259916 N-[4-(cyanocyclobutyl)-phenyl]{2-[(4-pyridylmethyl)amino]phenyl}carboxamidefor example; inhibit the effect of VEGF receptor tyrosine kinase; use treating cancer, diabetes, and angiogenesis
12/23/2004	US20040259914 chemokine receptor (CCR) inhibitors for treating allergic or inflammatory diseases such as asthma or rheumatoid arthritis, multiple sclerosis, inflammatory bowel diseases; 2-((p-fluorobenzyl)piperidinylmethyl)cyclohexylureas of given formula
12/23/2004	US20040259913 Diamide invertebrate pest control agents
12/23/2004	US20040259910 Glutamine fructose-y-phosphate amidotransferase (GFAT) inhibitors
12/23/2004	US20040259904 for treating cancer; 4'-(6,7-dimethoxy-1,4-dihydroindeno[1,2-c]pyrazol-3-yl)-1,1'-biphenyl-4-yl 1,4'-bipiperidine-1'-carboxylate for example
12/23/2004	US20040259897 transplant rejection, rheumatoid arthritis, osteoarthritis, diabetes, asthma, inflammatory bowel disease, and chronic obstructive pulmonary disease; inhibitors of Lymphocyte Function-associated Antigen 1 (LFA-1)/intercellular adhesion molecule (ICAM); 2,4-dioxo-1,3,7-triazaspiro[4.4]nonanes
12/23/2004	US20040259893 Use of tyrosine kinase inhibitions for treating allergic diseases
12/23/2004	US20040259892 c-kit inhibitor; unable to promote death of IL-3 dependent cells cultured in presence of IL-3; N-phenyl-2-pyrimidine-amine derivatives; 4-(4-methylpiperazine-1-ylmethyl)-N-[4-methyl-3-(4-pyridine-3-yl)pyrimidine-2 ylamino)phenyl]-benzamide
12/23/2004	US20040259890 trans-3'-oxo-N-(trans-4-phenylcyclohexyl)-spiro[cyclohexane-1,1'(3'H)-isobenzofuran]-4-carboxamide e.g.; neuropeptide Y receptor antagonists for treatment of bulimia, obesity or diabetes for example
12/23/2004	US20040259887 Cannabinoid receptor ligands and uses thereof
12/23/2004	US20040259885 Urea kinase inhibitors
12/23/2004	US20040259884 Antiproliferative agents; antitumor agents; using 1-(4,5-bis(4-chlorophenyl)-2-(2,4-dimethoxyphenyl)-4,5-imidazol-1-yl)-2-methylpropan-1-one
12/23/2004	US20040259881 Nitrogenous heterocyclic compounds
12/23/2004	US20040259879 Antiarthritic agents; colon cancer, neurodegenerative agents
12/23/2004	US20040259870 Antidiabetic agents; obesity; controlling appetite
12/23/2004	US20040259868 Serine protease inhibitors
12/23/2004	US20040259867 Antiproliferative agents; antitumor agents
12/23/2004	US20040259866 Calcium channel blockers comprising two benzhydril moieties
12/23/2004	US20040259864 Substituted pyrimidinone derivatives as ligands of integrin receptors
12/23/2004	US20040259863 Type 4 phosphodiesterase inhibitors and uses thereof
12/23/2004	US20040259859 Therapy for diseases caused by opioid receptors; irratible bowel disorders; drug abuse; antidepressants; anxiolytic agents; schizophrenia; eating disorders
12/23/2004	US20040259858 such as 3-(2-methyl-4-pyrrolidin-1-yl-quinolin-7-yl-methoxy)-benzonitrile; neuropeptide y receptor antagonists; for treatment or prevention of arthritis, cardiovascular diseases, diabetes, renal failure, eating disorders and obesity
12/23/2004	US20040259843 Antidiabetic agents; hyperglycemic agents; obesity; atherosclerosis; immunomodulatory agents
12/23/2004	US20040259826 Mitotic kinesin inhibitors
12/23/2004	US20040255397 Compounds derived from diaminopyrazole substituted by a heteroaromatic radical and their use in oxidation dyeing of keratimous fibers
12/23/2004	CA2756058A1 Fused compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor
12/23/2004	CA2529090A1 2-aminopyrimidine derivatives as raf kinase inhibitors
12/23/2004	CA2529068A1 Pyrimidine derivatives as cannabinoid receptor ligands
12/23/2004	CA2528993A1 Process for preparing 2-[(pyridinyl)methyl]sulfinyl-substituted benzimidazoles and novel chlorinated derivatives of pantoprazole
12/23/2004	CA2528929A1 Cyclic tertiary amine compound
12/23/2004	CA2528652A1 Nk1 antagonist
12/23/2004	CA2528644A1 Novel piperazinyl-aryloxy and piperazinyl-heteroaryloxy-n-aryl lactams
12/23/2004	CA2528321A1 Tetrahydrocarbazole derivatives and their pharmaceutical use
12/23/2004	CA2527851A1 Hepatitis c virus inhibitors
12/23/2004	CA2527582A1 Prodrugs of mitotic kinesin inhibitors
12/23/2004	CA2527037A1 2,3-substituted 5,6-diaryl-pyrazine derivatives as cb1 modulators
12/23/2004	CA2527035A1 3-substituted 5,6-diaryl-pyrazine-2-carboxamide and -2-sulfonamide derivatives as cb1 modulators
12/23/2004	CA2527033A1 2-substitued 5,6-diaryl-pyrazine derivatives as cb1 modulators
12/23/2004	CA2526872A1 Fused compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor
12/23/2004	CA2526518A1 1-aryl-4-(aryloxycarbonyl)-piperazine derivatives for use as inhibitors of hormone sensitive lipase
12/23/2004	CA2526387A1 Benzamide derivative or salt thereof
12/23/2004	CA2526204A1 Pyridinyl carbamates as hormone-sensitive lipase inhibitors
12/23/2004	CA2526048A1 Bicyclic indolyl derivatives and methods of their use as serotonergic agents
12/23/2004	CA2525207A1 Substituted piperidine carbamates for use as inhibitors of hormone sensitive lipase
12/22/2004	EP1489418A1 Novel fluorescent label compounds
12/22/2004	EP1489155A1 Material for organic electroluminescent devices and organic electroluminescent devices made by using the same
12/22/2004	EP1489080A1 Process for producing cilostazol
12/22/2004	EP1488792A2 Quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase
12/22/2004	EP1487824A1 Diamino-pyrimidines and their use as angiogenesis inhibitors
12/22/2004	EP1487823A1 Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with cdk inhibitory activity
12/22/2004	EP1487822A2 Pyrrole-2,5-dione derivatives and their use as gsk-3 inhibitors
12/22/2004	EP1487821A1 Benzodiazepine-substituted piperidines for utilization in the treatment of cardiovascular diseases
12/22/2004	EP1487820A1 Crystalline forms of rabeprazole sodium
12/22/2004	EP1487819A2 Azepane derivatives and their use as atk1 inhibitors
12/22/2004	EP1487818A1 Alkylammonium salts of omeprazole and esomeprazole
12/22/2004	EP1487807A2 New compounds
12/22/2004	EP1487806A1 4-anilino quinazoline derivatives as antiproliferative agents
12/22/2004	EP1487805A1 Pyrimidine derivatives
12/22/2004	EP1487804A2 Aminoindazole derivatives as protein-kinase inhibitors
12/22/2004	EP1487803A1 Indazoles substituted with an anti-cancerous activity
12/22/2004	EP1487802A1 Neurotensin active 2,3-diaryl-pyrazolidine derivatives
12/22/2004	EP1487801A1 7-arylsulfonamido-2,3,4,5-tetrahydro-1h-benzo[d]azepine derivatives with 5-ht6 receptor affinity for the treatment of cns disorders
12/22/2004	EP1487800A1 Phenanthridinones as parp inhibitors
12/22/2004	EP1487799A1 9-aminoacridine derivatives and process for the preparation thereof
12/22/2004	EP1487798A1 Substituted tetrahydroisoquinolines as c5a receptor modulators
12/22/2004	EP1487797A1 Hetero-bridge substituted 8-arylquinoline pde4 inhibitors
12/22/2004	EP1487794A1 Monocyclic aroylpyridinones as antiinflammatory agents
12/22/2004	EP1487792A1 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators
12/22/2004	EP1487763A2 Use of microfabricated devices for radiosynthesis
12/22/2004	EP1487474A2 Intranasal administration of mc4-r agonists

1 ... 600 601 602 603 604 605 606 607 608 609 610 611 612 613 614 615 616 617 618 619 620 ... 1080